These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31482435)

  • 21. [Beta-adrenergic receptors in the cardiovascular system. The participation of propranolol insensitive beta-adrenoceptors in the regulation of the cardiovascular system].
    Malinowska B; Kozłowska H; Zakrzeska A; Kwolek G
    Kardiol Pol; 2005 Oct; 63(4 Suppl 2):S399-408. PubMed ID: 20527395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioligand binding characteristics of beta 2-adrenoceptors of cultured melanoma cells.
    Steinkraus V; Nose M; Mensing H; Körner C
    Br J Dermatol; 1990 Aug; 123(2):163-70. PubMed ID: 1976019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of adrenergic signaling in skin cancer progression: possible repurposing of β-blockers for treatment of skin cancer.
    Yang EV; Eubank TD
    Cancer Biomark; 2013; 13(3):155-60. PubMed ID: 23912487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do β-blockers slow down melanoma progression?
    Lens M
    Arch Intern Med; 2011 Oct; 171(18):1686-7; author reply 1687. PubMed ID: 21987205
    [No Abstract]   [Full Text] [Related]  

  • 25. Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression.
    Calvani M; Pelon F; Comito G; Taddei ML; Moretti S; Innocenti S; Nassini R; Gerlini G; Borgognoni L; Bambi F; Giannoni E; Filippi L; Chiarugi P
    Oncotarget; 2015 Mar; 6(7):4615-32. PubMed ID: 25474135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three Generations of β-blockers: History, Class Differences and Clinical Applicability.
    do Vale GT; Ceron CS; Gonzaga NA; Simplicio JA; Padovan JC
    Curr Hypertens Rev; 2019; 15(1):22-31. PubMed ID: 30227820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I; Edes I
    Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiproliferative effects of β-blockers on human colorectal cancer cells.
    Coelho M; Moz M; Correia G; Teixeira A; Medeiros R; Ribeiro L
    Oncol Rep; 2015 May; 33(5):2513-20. PubMed ID: 25812650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacology of beta-blockers: classical aspects and recent developments.
    Haeusler G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S1-9. PubMed ID: 11527109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct labelling of beta 2-adrenoceptors. Comparison of binding potency of 3H-ICI 118,551 and blocking potency of ICI 118,551.
    Lemoine H; Ehle B; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):40-51. PubMed ID: 2866450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of endogenous noradrenaline in the beta-blocker withdrawal phenomenon--studies with cultured heart cells.
    Reithmann C; Thomschke A; Werdan K
    Klin Wochenschr; 1987 Apr; 65(7):308-16. PubMed ID: 2884347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β-blockers in the treatment of periocular infantile hemangioma.
    Al-Haddad C; El Salloukh NA; El Moussawi Z
    Curr Opin Ophthalmol; 2019 Sep; 30(5):319-325. PubMed ID: 31394556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β-Blocker use and reduced disease progression in patients with thick melanoma: 8 years of follow-up.
    De Giorgi V; Grazzini M; Benemei S; Marchionni N; Geppetti P; Gandini S
    Melanoma Res; 2017 Jun; 27(3):268-270. PubMed ID: 28346289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unveil the mysterious mask of cytokine-based immunotherapy for melanoma.
    Xu DH; Zhu Z; Xiao H; Wakefield MR; Bai Q; Nicholl MB; Ding VA; Fang Y
    Cancer Lett; 2017 May; 394():43-51. PubMed ID: 28254411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives.
    Coelho M; Soares-Silva C; Brandão D; Marino F; Cosentino M; Ribeiro L
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):275-291. PubMed ID: 27709364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-Adrenergic Signaling in Lung Cancer: A Potential Role for Beta-Blockers.
    Nilsson MB; Le X; Heymach JV
    J Neuroimmune Pharmacol; 2020 Mar; 15(1):27-36. PubMed ID: 31828732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactive oxygen species may have antitumor activity in metastatic melanoma.
    Tuma RS
    J Natl Cancer Inst; 2008 Jan; 100(1):11-2. PubMed ID: 18159075
    [No Abstract]   [Full Text] [Related]  

  • 38. FoxP3 expression on melanoma cells is related to early visceral spreading in melanoma patients treated by electrochemotherapy.
    Quaglino P; Osella-Abate S; Marenco F; Nardò T; Gado C; Novelli M; Savoia P; Bernengo MG
    Pigment Cell Melanoma Res; 2011 Aug; 24(4):734-6. PubMed ID: 21696572
    [No Abstract]   [Full Text] [Related]  

  • 39. Beta 2-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Quantitative discrepancies with binding and adenylate cyclase stimulation.
    Kaumann AJ; Lemoine H
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):403-11. PubMed ID: 2885760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BEL β-Trefoil Reduces the Migration Ability of RUNX2 Expressing Melanoma Cells in Xenotransplanted Zebrafish.
    Valenti MT; Marchetto G; Perduca M; Tiso N; Mottes M; Dalle Carbonare L
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.